MA40303A1 - Peptides macrocycliques utiles comme immunomoldulateurs - Google Patents
Peptides macrocycliques utiles comme immunomoldulateursInfo
- Publication number
- MA40303A1 MA40303A1 MA40303A MA40303A MA40303A1 MA 40303 A1 MA40303 A1 MA 40303A1 MA 40303 A MA40303 A MA 40303A MA 40303 A MA40303 A MA 40303A MA 40303 A1 MA40303 A1 MA 40303A1
- Authority
- MA
- Morocco
- Prior art keywords
- immunomodulators
- peptides useful
- macrocyclic peptides
- useful
- macrocyclic
- Prior art date
Links
- 239000002955 immunomodulating agent Substances 0.000 title abstract 2
- 229940121354 immunomodulator Drugs 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés qui sont des immunomodulateurs et qui sont donc utiles pour l'amélioration de diverses maladies, notamment le cancer et des maladies infectieuses.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462079944P | 2014-11-14 | 2014-11-14 | |
| PCT/US2015/060265 WO2016077518A1 (fr) | 2014-11-14 | 2015-11-12 | Peptides macrocycliques utiles comme immunomoldulateurs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA40303A1 true MA40303A1 (fr) | 2018-08-31 |
| MA40303B1 MA40303B1 (fr) | 2020-01-31 |
Family
ID=58688528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA40303A MA40303B1 (fr) | 2014-11-14 | 2015-11-12 | Peptides macrocycliques utiles comme immunomoldulateurs |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR102651A1 (fr) |
| MA (1) | MA40303B1 (fr) |
-
2015
- 2015-11-12 MA MA40303A patent/MA40303B1/fr unknown
- 2015-11-13 AR ARP150103712A patent/AR102651A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AR102651A1 (es) | 2017-03-15 |
| MA40303B1 (fr) | 2020-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39285A (fr) | Peptides macrocycliques utiles comme immunomoldulateurs | |
| SA519402400B1 (ar) | تركيبات وطرق لعلاج أمراض الهيموجلوبين | |
| GEP20247593B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
| MX2020009649A (es) | Anticuerpos monoclonales contra bcma. | |
| PH12018501378A1 (en) | Compositions and methods for the treatment of hemoglobinopathies | |
| MX2018009325A (es) | Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn). | |
| EA201891200A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| PH12017500296A1 (en) | Anti-tigit antibodies | |
| MX2018016038A (es) | Compuestos y metodos para modular la funcion del acido ribonucleico (arn). | |
| EA201891202A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| EA201891201A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| PH12016501107A1 (en) | Biaryl compounds useful for the treatment of human diseases in oncology, neurology and immunology | |
| EA201890050A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| EA201890049A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| MX2018010295A (es) | Anticuerpos que tienen especificidad para atenuador de linfocitos b y t (btla) y usos de los mismos. | |
| MX2017016169A (es) | Anticuerpos anti-her2 y metodos de uso. | |
| EA201692526A1 (ru) | Замещенные [1,2,4]триазольные соединения | |
| PH12019501872A1 (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| MX388026B (es) | Compuestos y métodos para modular la tirosina cinasa de bruton. | |
| SG11201811429XA (en) | Flow reactor | |
| MX2017003953A (es) | Compuestos que contrarrestan el mal olor bajo, de cobertura-alta y metodos uso. | |
| MX2020003219A (es) | Anticuerpos que tienen especificidad para btn2 y usos de los mismos. | |
| MX382092B (es) | Compuestos heterocíclicos para el tratamiento de enfermedades. | |
| MX2020000636A (es) | Proteinas sinteticas y usos terapeuticos de las mismas. | |
| MX370897B (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades, |